Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey

References

• Lintzeri DA, Constantinou A, Hillmann K, Ghoreschi K, Vogt A, Blume‐ Peytavi U. Alopecia areata – current understanding and management. JDDG. 2022;20:59–90.
   Google Scholar
• Muntyanu A, Gabrielli S, Donovan J, et al. The burden of alopecia areata: a scoping review focusing on quality of life, mental health and work productivity. J Eur Acad Dermatol Venereol Epub. 2023;37(8):1490–1520. doi:10.1111/jdv.18926
   Web of Science ®Google Scholar
• Mesinkovska N, King B, Mirmirani P, Ko J, Cassella J. Burden of illness in alopecia areata: a cross-sectional online survey Study. J Investig Dermatol Symp Proc. 2020;20(1):S62–S68. doi:10.1016/j.jisp.2020.05.007
   PubMedGoogle Scholar
• Burns LJ, Mesinkovska N, Kranz D, Ellison A, Senna MM. Cumulative life course impairment of alopecia areata. Int J Trichol. 2020;12(5):197–204. doi:10.4103/ijt.ijt_99_20
   PubMedGoogle Scholar
• Lai VWY, Chen G, Gin D, Sinclair R. Systemic treatments for alopecia areata: a systematic review. Australas J Dermatol. 2019;60(1):e1–e13. doi:10.1111/ajd.12913
   PubMed Web of Science ®Google Scholar
• Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. British association of dermatologists’ guidelines for the management of alopecia areata 2012. Br J Dermatol. 2012;166(5):916–926. doi:10.1111/j.1365-2133.2012.10955.x
   PubMed Web of Science ®Google Scholar
• Rossi A, Muscianese M, Piraccini BM, et al. Italian guidelines in diagnosis and treatment of alopecia areata. G Ital Dermatol Venereol. 2019;154(6):609–623. doi:10.23736/S0392-0488.19.06458-7
   PubMed Web of Science ®Google Scholar
• Fukuyama M, Ito T, Ohyama M. Alopecia areata: current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese dermatological association guidelines. J Dermatol. 2022;49(1):19–36. doi:10.1111/1346-8138.16207
   PubMed Web of Science ®Google Scholar
• Fridman M, Ray M, Gandhi K, Shy ME, Mostaghimi A. Treatment patterns and treatment satisfaction among adults with alopecia areata in the United States. Adv Ther. 2022;39(12):5504–5513. doi:10.1007/s12325-022-02338-4
   PubMed Web of Science ®Google Scholar
• Andersen YMF, Nymand L, DeLozier AM, Burge R, Edson-Heredia E, Egeberg A. Patient characteristics and disease burden of alopecia areata in the Danish skin cohort. BMJ Open. 2022;12:e053137.
   PubMedGoogle Scholar
• Edson‐Heredia E, Aranishi T, Isaka Y, Anderson P, Marwaha S, Piercy J. Patient and physician perspectives on alopecia areata: a real-world assessment of severity and burden in Japan. J Dermatol. 2022;49(6):575–583. doi:10.1111/1346-8138.16360
   PubMed Web of Science ®Google Scholar
• Yan D, Fan H, Chen M, et al. The efficacy and safety of JAK inhibitors for alopecia areata: a systematic review and meta-analysis of prospective studies. Front Pharmacol. 2022;13:950450. doi:10.3389/fphar.2022.950450
   PubMedGoogle Scholar
• Pourang A, Mesinkovska NA. New and emerging therapies for alopecia areata. Drugs. 2020;80(7):635–646. doi:10.1007/s40265-020-01293-0
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Olumiant, baricitinib EPAR. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/olumiant. Accessed July 3, 2023.
   Google Scholar
• Food and Drug Administration. Olumiant (baricitinib). Highlights of prescribing information. Available from: https://pi.lilly.com/us/olumiant-uspi.pdf. Accessed July 3, 2023.
   Google Scholar
• Aldhouse NVJ, Kitchen H, Knight S, et al. “You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient-Rep Outcomes. 2020;4(1):76. doi:10.1186/s41687-020-00240-7
   PubMedGoogle Scholar
• Wyrwich KW, Kitchen H, Knight S, et al. Development of the scalp hair assessment PRO™ measure for alopecia areata. Br J Dermatol. 2020;183(6):1065–1072. doi:10.1111/bjd.19024
   PubMed Web of Science ®Google Scholar
• Wyrwich KW, Kitchen H, Knight S, et al. Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) measures for eyebrow, eyelash and nail assessment in alopecia areata. Am J Clin Dermatol. 2020;21(5):725–732. doi:10.1007/s40257-020-00545-9
   PubMed Web of Science ®Google Scholar
• Finlay A, Khan G Dermatology Life Quality Index (DLQI). Available from: https://www.nhsfife.org/media/32589/dermatology-life-quality-index-dlqi.pdf. Accessed July 3, 2023.
   Google Scholar
• Hongbo Y, Thomas CL, Harrison MA, Sam Salek M, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol. 2005;125(4):659–664. doi:10.1111/j.0022-202X.2005.23621.x
   PubMed Web of Science ®Google Scholar
• Al-Mutairi N, Eldin ON. Clinical profile and impact on quality of life: seven years experience with patients of alopecia areata. Indian J Dermatol Venereol Leprol. 2011;77(4):489–493. doi:10.4103/0378-6323.82411
   PubMed Web of Science ®Google Scholar
• Liu LY, King BA, Craiglow BG. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): a systematic review. J Am Acad Dermatol. 2016;75(4):806–812.e3. doi:10.1016/j.jaad.2016.04.035
   PubMed Web of Science ®Google Scholar
• Abedini R, Hallaji Z, Lajevardi V, Nasimi M, Karimi Khaledi M, Tohidinik HR. Quality of life in mild and severe alopecia areata patients. Int J Womens Dermatol. 2018;4(2):91–94. doi:10.1016/j.ijwd.2017.07.001
   PubMedGoogle Scholar
• Senna M, Ko J, Glashofer M, et al. Predictors of QOL in patients with alopecia areata. J Invest Dermatol. 2022;142(10):2646–2650.e3. doi:10.1016/j.jid.2022.02.019
   PubMed Web of Science ®Google Scholar
• Lee S, Lee H, Lee CH, Lee WS. Comorbidities in alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):466–477.e16. doi:10.1016/j.jaad.2018.07.013
   PubMed Web of Science ®Google Scholar
• Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review. J Am Acad Dermatol. 2021;85(1):162–175. doi:10.1016/j.jaad.2020.06.047
   PubMed Web of Science ®Google Scholar
• Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey study. Br J Dermatol. 2019;180(6):1377–1389. doi:10.1111/bjd.17463
   PubMed Web of Science ®Google Scholar
• Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis. 2017;3:17011.
   PubMed Web of Science ®Google Scholar
• Messenger AG, Bleehen SS. Alopecia areata: light and electron microscopic pathology of the regrowing white hair. Br J Dermatol. 1984;110(2):155–162. doi:10.1111/j.1365-2133.1984.tb07461.x
   PubMed Web of Science ®Google Scholar
• Jia W-X, Mao Q-X, Xiao X-M, Li Z-L, Yu R-X, Li C-R. Patchy alopecia areata sparing gray hairs: a case series. Adv Derm Allergol. 2014;2:113–116.
   Google Scholar
• Tan E, Tay YK, Giam YC. A clinical study of childhood alopecia areata in Singapore. Pediatr Dermatol. 2002;19(4):298–301. doi:10.1046/j.1525-1470.2002.00088.x
   PubMed Web of Science ®Google Scholar
• Villasante Fricke A, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Invest Dermatol. 2015;8:397–403. doi:10.2147/CCID.S53985
   PubMed Web of Science ®Google Scholar
• Spencer-Bonilla G, Quiñones AR, Montori VM. Assessing the burden of treatment. J Gen Intern Med. 2017;32(10):1141–1145. doi:10.1007/s11606-017-4117-8
   PubMed Web of Science ®Google Scholar
• Alhanshali L, Buontempo MG, Lo Sicco KI, Shapiro J. Alopecia areata: burden of disease, approach to treatment, and current unmet needs. Clin Cosmet Invest Dermatol. 2023;16:803–820. doi:10.2147/CCID.S376096
   PubMed Web of Science ®Google Scholar